Volume 15, Number 11—November 2009
Letter
Preexisting Immunity to Pandemic (H1N1) 2009
Table
Conserved MHC class I antigen-restricted epitopes present in HA and NP proteins of pandemic (H1N1) 2009 virus*
MHC antigen |
Epitope
position |
Sequence |
Identified in selected
virus isolates |
---|---|---|---|
HA | |||
HLA-A*0201 | 344–353 | GLFGAIAGFI | A/New Caledonia/20/1999 (H1N1) A/Solomon Islands/3/2006 (H1N1) A/Macau/229/2008 (H1N1) A/Managua/254.01/2008(H1N1 |
NP | |||
HLA-A1 | 44–52 | CTELKLSDY | A/Hong Kong/HKU4/2004 (H3N2) |
HLA-A*0101 | A/Canterbury/200/2004 (H3N2) | ||
HLA-A3 | 265–273 | ILRGSVAHK | A/New Caledonia/20/1999 (H1N1) |
A/New York/55/2004 (H3N2) | |||
A/Managua/254.01/2008(H1N1) | |||
A/Taiwan/2645/2006 (H1N1) | |||
HLA-B27 | 380–393 | ELRSRYWAIRTRSG | A/New Caledonia/20/1999 (H1N1) |
A/Taiwan/2645/2006 (H1N1) | |||
A/Managua/254.01/2008(H1N1) | |||
A/Florida/UR06-0383/2007(H1N1) | |||
HLA-B27 | 174–184 | RRSGAAGAAVK | A/New Caledonia/20/1999 (H1N1) |
A/New York/55/2004 (H3N2) | |||
A/California/UR07-0067/2008 (H3N2) | |||
A/Taiwan/2645/2006 (H1N1) | |||
HLA-B*2705 | 357–370 | KLSTRGVQIASNEN | A/New Caledonia/20/1999 (H1N1) |
A/New York/55/2004 (H3N2) | |||
A/Hong Kong/HKU77/2005 (H3N2) | |||
A/Managua/3153.01/2008 (H1N1) | |||
HLA-B*2705 | 383–391 | SRYWAIRTR | A/New Caledonia/20/1999 |
A/Taiwan/2645/2006 (H1N1) | |||
A/Managua/4537.03/2008 (H1N1) | |||
A/Florida/UR07-0026/2008 (H1N1) | |||
HLA-B*2702 | 381–388 | LRSRYWAI | A/New Caledonia/20/1999 |
A/Florida/UR06-0383/2007(H1N1) | |||
HLA-B*4002 | 251–259 | AEIEDLIFL | A/Canterbury/200/2004 (H3N2) |
A/Hong Kong/HKU71/2005 (H3N2) | |||
HLA-B8 | 225–233 | ILKGKFQTA | A/New Caledonia/20/1999 |
A/California/UR07-0067/2008 (H3N2) | |||
A/Taiwan/2645/2006 (H1N1) | |||
HLA-B8 | 380–388 | ELRSRYWAI | A/New Caledonia/20/1999 (H1N1) |
HLA-B*0801 | A/Taiwan/2645/2006 (H1N1) | ||
A/Managua/107.01/2008 (H1N1) | |||
A/Florida/UR07-0026/2008 (H1N1) |
*HA, hemagglutinin; NP, nucleoprotein; MHC, major histocompatibility complex; NA, neuraminidase. Epitope binding to and/or activation of specific lymphocytes prepared from human peripheral blood mononuclear cells (PBMC): MHC-tetramer staining; T-cell receptor binding; ELISPOT and intracellular cytokine staining (interferon γ), and/or 51Chromine release and killing have been demonstrated in published studies. Data on epitope characterization were collected from the Immune Epitope Database (IEDB; www.immuneepitope.org) (4).
References
- Centers for Disease Control and Prevention. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep. 2009;58:521–4.PubMedGoogle Scholar
- Centers for Disease Control and Prevention. Update: infections with a swine-origin influenza A (H1N1) virus—United States and other countries, April 28, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:431–3.PubMedGoogle Scholar
- Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325:197–201. DOIPubMedGoogle Scholar
- Kwok WW, Yang J, James E, Bui J, Huston L, Roti M. Identification of 13mer epitopes for DRB1*0101, DRB1*0401, DRB1*0404, and DRB1*0701 restricted CD4+ T cell epitopes for tetanus toxoid and several influenza proteins 2009 [cited 2009 Sep 2]. Available from http://immuneepitope.org/refId/1013360
- Kosor Krnic E, Gagro A, Drazenovic V, Kuzman I, Jeren T, Cecuk-Jelicic E, Enumeration of haemagglutinin-specific CD8+ T cells after influenza vaccination using MHC class I peptide tetramers. Scand J Immunol. 2008;67:86–94.PubMedGoogle Scholar
- Couch RB. Seasonal inactivated influenza virus vaccines. Vaccine. 2008;26(Suppl 4):D5–9. DOIPubMedGoogle Scholar
- Boon AC, de Mutsert G, van Baarle D, Smith DJ, Lapedes AS, Fouchier RA, Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol. 2004;172:2453–60.PubMedGoogle Scholar
- McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, T cell responses are better correlates of vaccine protection in the elderly. J Immunol. 2006;176:6333–9.PubMedGoogle Scholar
- McMichael AJ, Gotch FM, Noble GR, Beare PA. Cytotoxic T-cell immunity to influenza. N Engl J Med. 1983;309:13–7.PubMedGoogle Scholar